Subsequent GenomeDx Reanalysis (charged)
Use
Subsequent GenomeDx Reanalysis (charged) is a follow‑up analysis of previously performed genome sequencing data at GeneDx, intended for situations where the initial report requires reevaluation based on updated clinical information or novel scientific findings. It enables providers to revisit original sequencing data to assess newly classified pathogenic or likely pathogenic variants, changes in variant significance, and emerging gene‑disease associations, enhancing diagnostic yield while avoiding additional sequencing.
Special Instructions
Not provided.
Limitations
Limited to reinterpretation of existing genomic data; no new sequencing is performed. Diagnostic yield depends on the original data quality, existing coverage, and evolving variant classification databases. Results may not include novel findings absent in the original data set or variants outside the previously captured regions. Delays may occur if updated phenotypic or family history information is missing.
Methodology
NGS
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Extracted DNA
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Must be from prior genome sequencing submitted to GeneDx (no new specimen required)
Other tests from different labs that may be relevant